Doxazosin-Associated Urinary Incontinence
Peripheral alpha-1 blockers, including doxazosin, can be associated with urinary incontinence in some patients. [1]
Evidence includes an observational cohort study linking peripheral alpha-blocker use to higher odds of urinary incontinence and a case report showing incontinence improvement after discontinuation of doxazosin. [1, 2]
Evidence Supporting Potential Harm
A longitudinal cohort study of community-dwelling older women found peripheral alpha-blocker use (including doxazosin) was associated with increased odds of urinary incontinence (adjusted odds ratio 4.47; 95% confidence interval 1.79 to 11.21). [1]
In post hoc analysis, the odds of urinary incontinence were higher when peripheral alpha-blockers were used with loop diuretics (adjusted odds ratio 8.81; 95% confidence interval 1.78 to 43.53). [1]
A case report described worsening urinary control in a patient taking doxazosin after prostate cancer treatment, with improvement after doxazosin discontinuation. [2]
Mechanistic Considerations
Alpha-1 blockade can reduce outlet resistance at the bladder neck/internal sphincter and may contribute to urinary control problems. [2]
Patient-Specific Factors Increasing Concern
Older adults may be more susceptible to medication-related urinary incontinence. [1]
Concomitant loop diuretic use may increase the likelihood of incontinence when a peripheral alpha-blocker is present. [1]
Post-prostate cancer treatment states involving urinary sphincter function may increase sensitivity to alpha-blocker effects on urinary control. [2]
Management Approach
Medication-related urinary incontinence should prompt medication review and consideration of dose reduction or discontinuation of the suspected agent under prescriber guidance. [1, 2]
If discontinuation is considered, monitoring for both urinary incontinence improvement and blood pressure control is appropriate. [1, 2]
When to Seek Clinical Evaluation
Prompt clinical evaluation is recommended for new or worsening urinary incontinence after starting doxazosin, especially when other causes are possible (urinary retention, infection, or progression of lower urinary tract symptoms). [1, 2]
Ongoing urinary incontinence after medication adjustment warrants further urologic and primary care assessment. [1, 2]